TROG 08.08 (TOP GEAR)
Primary sponsor: Australasian Gastro-Intestinal Trials Group (AGITG)
Collaborating groups: Trans Tasman Radiation Oncology Group (TROG); Canadian Clinical Trials Group (CCTG); European Organisation for Research & Treatment of Cancer (EORTC)
A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.
The main aim of this international study is to investigate whether treatment with chemotherapy plus radiotherapy has a better outcome than chemotherapy alone in patients undergoing surgery for resectable gastric cancer.
Current participating centres (PDF)
Current accrual graph (PDF)
Expected date of accrual completion
31 December 2020
Professor Trevor Leong, Peter MacCallum Cancer Centre, VIC
Clinical Trial Coordinator
Phone: +61 2 9562 5316
TROG trial 08.08 on Australian Cancer Trials website
Trial resources for TROG members
TROG 08.08 member page